Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

Radiopharmacies Now on Dealmakers’ Radar

You can’t get much more “specialty” in the specialty pharmacy business than to deal in radiopharmaceuticals. Two recent deals, announced in August, show this area is heating up. IBA Molecular, a global maker and distributor of radiopharmaceutical products, agreed to pay approximately $613 million for Mallinckrodt’s (NYSE: MNK) nuclear imaging business, including a portfolio of diagnostic imaging products. The U.S. market accounts for approximately two thirds of the division’s current annual revenues. For Mallinckrodt, the sale continues its strategic portfolio transformation, as the company evolves to handle specialty pharmaceuticals that don’t glow. IBA... Read More »

Henry Schein Picks up Another Dental Distribution Service

In late August 2016, Henry Schein, Inc. (NASDAQ: HSIC) announced its seventh dental acquisition since 2014. The acquisition of Marrodent gave the global dental products giant a presence in Poland, where Marrodent distributes dental equipment and dental laboratory supplies. With this addition, Henry Schein’s dental business now has operations or affiliates in 27 countries. In 2014, Henry Schein purchased five European dental companies from Arseus NV (EBR: RCUS), as well as New Jersey-based Lincoln Dental Supply, a supplier of dental products and equipment, and France-based Sirona Direct, the dental distribution business of Sirona Dental Systems Inc. (NASDAQ: SIRO). In 2015, the... Read More »

BioClinica Changes Hands as CRO Market Heats Up

The market for contract research organizations (CROs) is hot in 2016. Fourteen deals have been announced so far this year, compared with five in all of 2015, 11 in 2014 and eight in 2013. The latest deal was announced on August 22, as JLL Partners and Water Street Healthcare Partners exited their investment in BioClinica, Inc. and the UK-based private equity firm Cinven stepped in, for an undisclosed price. The original investment for the global clinical trial management company, then trading under the NASDAQ ticker symbol BIOC, was announced on January 30, 2013, for $123 million (1.6x revenue and 11.8x EBITDA). That deal included the acquisition of medical imaging company CoreLab... Read More »

Specialty Pharmacy Extends Reach in Healthcare

Genoa, a QoL Healthcare Company, a leading behavioral health specialty pharmacy company, has acquired the behavioral health and residential care services division of Advanced Care Pharmacy Services, including 13 of its pharmacies in Michigan. Genoa is a portfolio company of Advent International. In November 2015, Genoa acquired 1DocWay, the nation’s largest outpatient telepsychiatry provider, for an undisclosed price. Advanced Care Pharmacy Services is a privately-held Alabama-based provider of specialized pharmacy services for a variety of care settings. Genoa’s purchase, which did not disclose a price, increases its number of Michigan-based pharmacies to 24, and 325 nationally.... Read More »

Arizona Urgent Care Market Tightens

Banner Health just threw its hat in the ring for the title of largest urgent care operator in Arizona. The not-for-profit health system, which operates 29 hospitals in seven states, just announced its acquisition of 32 Urgent Care Extra facilities in that state, primarily around Phoenix and Tucson. The clinics will be rebranded as Banner Urgent Care and join three other urgent care centers currently run by the health system. Two of those are in Colorado, and one is in Arizona. Banner plans to have as many as 50 urgent care centers in Arizona by the end of 2017, which would make it the largest urgent care operator in the state. Banner may have some competition from two other... Read More »

Patient Experience Data Draws Big Money

EQT, a Swedish private equity firm with approximately €30 billion in raised capital, announced it was taking Press Ganey Holdings (NYSE: PGND) private with a purchase price of $2.35 billion, or $40.50 a share. Press Ganey made its mark by offering patient experience solutions to measure and analyze data collected directly from patients, including patient experience insights measured through several electronic modes; and caregiver engagement solutions comprising physician, nurse and, employee alignment and engagement solutions. It also provides clinical and quality solutions, such as Nursing Quality Indicators, a program that collects data on a set of nursing-sensitive process, structure,... Read More »